These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 619141)

  • 21. Biofunctional evaluation of two hydrogen bonds stabilizing the beta-turn in the acyclic component of oxytocin.
    Roy U; Gazis D; Schwartz IL; Roy J
    Int J Pept Protein Res; 1983 Oct; 22(4):398-403. PubMed ID: 6654586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and some pharmacological properties of oxytocin analogues having L-thiazolidine-4-carboxylic acid in position 7.
    Rosamond JD; Ferger MF
    J Med Chem; 1976 Jul; 19(7):873-6. PubMed ID: 940106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conformation-activity studies of oxytocin. Effects of structural modifications at corner positions of the beta-turns on the uterotonic activity.
    Smith CW; Botos CR; Skala G; Walter R
    J Med Chem; 1977 Nov; 20(11):1457-60. PubMed ID: 915905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxytocin analogs with oxygen-containing side chains in position 3.
    Gazis D; Schwartz IL; Cordopatis P; Theodoropoulos D
    Int J Pept Protein Res; 1986 Jun; 27(6):679-84. PubMed ID: 3759339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [5-(N4,N4-Dimethylasparagine),8-lysine]vasopressin: the first 5-position neurohypophyseal hormone analogue to retain to retain significant antidiuretic potency.
    Smith CW; Walter R; Stavropoulos G; Theodoropoulos D
    J Med Chem; 1980 Feb; 23(2):217-9. PubMed ID: 7359538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and pharmacology of novel analogues of oxytocin and deaminooxytocin: directed methods for the construction of disulfide and trisulfide bridges in peptides.
    Chen L; Zoulíková I; Slaninová J; Barany G
    J Med Chem; 1997 Mar; 40(6):864-76. PubMed ID: 9083475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and some pharmacological properties of [Glu(OMe)4]oxytocin and [Mpr1, Glu(OMe)4]oxytocin.
    Photaki I; Tzougraki C; Kotsira-Engonopoulos C
    Int J Pept Protein Res; 1979 Apr; 13(4):426-33. PubMed ID: 457336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [1-Deaminopenicillamine,4-threonine]oxytocin, a potent inhibitor of oxytocin.
    Manning M; Lowbridge J; Seto J; Haldar J; Sawyer WH
    J Med Chem; 1978 Feb; 21(2):179-82. PubMed ID: 621712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of novel bicyclic analogues derived from a potent oxytocin antagonist.
    Flouret G; Chaloin O; Borovickova L; Slaninová J
    J Pept Sci; 2006 Jun; 12(6):412-9. PubMed ID: 16432806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic antagonists of in vivo responses by the rat uterus to oxytocin.
    Lowbridge J; Manning M; Seto J; Haldar J; Sawyer WH
    J Med Chem; 1979 May; 22(5):565-9. PubMed ID: 458806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [2-o-Iodotyrosine]-oxytocin and [2-o-methyltyrosine]-oxytocin: basic pharmacology and comments on their potential use in binding studies.
    Pliska V; Marbach P; Vasák J; Rudinger J
    Experientia; 1977 Mar; 33(3):367-9. PubMed ID: 558109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroxy analogues of oxytocin and of lysine-vasopressin.
    Bisset GW; Chowdrey HS; Hope DB; Nilwises N; Wälti M
    Br J Pharmacol; 1979 Dec; 67(4):575-85. PubMed ID: 519108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analogues of a potent oxytocin antagonist with truncated C-terminus or shorter amino acid side chain of the basic amino acid at position 8.
    Flouret G; Chaloin O; Slaninová J
    J Pept Sci; 2003 Jun; 9(6):393-401. PubMed ID: 12846485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformationally restricted analogs of oxytocin; stabilization of inhibitory conformation.
    Lebl M; Hill P; Kazmierski W; Kárászová L; Slaninová J; Fric I; Hruby VJ
    Int J Pept Protein Res; 1990 Oct; 36(4):321-30. PubMed ID: 2079387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analogues of neurohypophyseal hormones, oxytocin and arginine vasopressin, conformationally restricted in the N-terminal part of the molecule.
    Kowalczyk W; Prahl A; Derdowska I; Sobolewski D; Olejnik J; Zabrocki J; Borovicková L; Slaninová J; Lammek B
    J Med Chem; 2006 Mar; 49(6):2016-21. PubMed ID: 16539389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological activity of oxytocin analogues containing conformationally-restricted residues in position 7.
    Fragiadaki M; Magafa V; Borovicková L; Slaninová J; Cordopatis P
    Eur J Med Chem; 2007 Jun; 42(6):799-806. PubMed ID: 17316912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A ureido group containing analogue of oxytocin comprising eight amino acid residues.
    Bodanszky M; Fagan DT; Walter R; Smith CW
    J Med Chem; 1978 Mar; 21(3):306-8. PubMed ID: 628007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Some biological properties of an "irreversible" antagonist of neurohypophyseal hormones, deamino-[Phe(4-BrCH2CONH)2]-oxytocin, and its isosteric analogue, deamino-[Phe(4-CH3CH2CONH)2]-oxytocin.
    Pliska V; Marbach P
    Eur J Pharmacol; 1978 Jun; 49(3):213-22. PubMed ID: 658139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analogs of oxytocin containing a pseudopeptide Leu-Gly bond of cis and trans configuration.
    Lebl M; Slaninová J; Johnson RL
    Int J Pept Protein Res; 1989 Jan; 33(1):16-21. PubMed ID: 2722396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Introduction of a cis-prolyl mimic in position 7 of the peptide hormone oxytocin does not result in antagonistic activity.
    Wittelsberger A; Patiny L; Slaninova J; Barberis C; Mutter M
    J Med Chem; 2005 Oct; 48(21):6553-62. PubMed ID: 16220972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.